TY - JOUR
T1 - Psychocognitive sequelae of critical illness and correlation with 3 months follow up
AU - Karnatovskaia, Lioudmila V.
AU - Schulte, Phillip J.
AU - Philbrick, Kemuel L.
AU - Johnson, Margaret M.
AU - Anderson, Brenda K.
AU - Gajic, Ognjen
AU - Clark, Matthew M.
N1 - Funding Information:
The study was supported by the Mayo Clinic Critical Care Research Committee. All authors have disclosed that they do not have any conflicts of interest.☆ The study was supported by the Mayo Clinic Critical Care Research Committee. All authors have disclosed that they do not have any conflicts of interest. We are most grateful for the assistance of Alberto Marquez, Midhat Mujic, Jennifer Bergstrom, Laurie Meade, Leah Struss, Suanne Weist and Kevin Curwick.☆ The study was supported by the Mayo Clinic Critical Care Research Committee. All authors have disclosed that they do not have any conflicts of interest.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/8
Y1 - 2019/8
N2 - Purpose: Over a third of critical illness survivors manifest significant psychocognitive impairments following discharge from the intensive care unit (ICU). It is not known which patient populations are at highest risk or if assessment at ICU discharge can guide outpatient treatment prioritization. Materials and methods: Prospective single center study in an academic medical center encompassing six types of ICUs assessed prevalence of psychocognitive morbidity based on ICU type and associations between initial and 3 month follow-up evaluation. Adult patients with >48 h ICU stays completed the Hospital Anxiety and Depression Scale (HADS), Impact of Events Scale-Revised (IES-R), and Montreal Cognitive Assessment-Blind (MoCA-blind). Results: Of 299 patients who underwent initial assessment, 174 (58%) completed follow-up. Length of stay, MoCA-Blind, HADS-A/D and IES-R scores were similar across ICUs. Most commonly observed impairment in-hospital was cognitive (58%) followed by anxiety (45%), acute stress (39%) and depression (37%). There were significant correlations between in-hospital and follow-up psychocognitive outcomes. Conclusions: There was no significant difference in impairment by ICU type. Significant correlation between the initial assessment and follow-up scores suggests that early screening of high risk patients may identify those at greatest risk of sustained morbidity and facilitate timely intervention.
AB - Purpose: Over a third of critical illness survivors manifest significant psychocognitive impairments following discharge from the intensive care unit (ICU). It is not known which patient populations are at highest risk or if assessment at ICU discharge can guide outpatient treatment prioritization. Materials and methods: Prospective single center study in an academic medical center encompassing six types of ICUs assessed prevalence of psychocognitive morbidity based on ICU type and associations between initial and 3 month follow-up evaluation. Adult patients with >48 h ICU stays completed the Hospital Anxiety and Depression Scale (HADS), Impact of Events Scale-Revised (IES-R), and Montreal Cognitive Assessment-Blind (MoCA-blind). Results: Of 299 patients who underwent initial assessment, 174 (58%) completed follow-up. Length of stay, MoCA-Blind, HADS-A/D and IES-R scores were similar across ICUs. Most commonly observed impairment in-hospital was cognitive (58%) followed by anxiety (45%), acute stress (39%) and depression (37%). There were significant correlations between in-hospital and follow-up psychocognitive outcomes. Conclusions: There was no significant difference in impairment by ICU type. Significant correlation between the initial assessment and follow-up scores suggests that early screening of high risk patients may identify those at greatest risk of sustained morbidity and facilitate timely intervention.
KW - Anxiety
KW - Cognitive impairment
KW - Critical illness survivors
KW - Depression
KW - Intensive care unit
KW - PTSD
KW - Post-intensive care syndrome
KW - Psychocognitive
UR - http://www.scopus.com/inward/record.url?scp=85065389637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065389637&partnerID=8YFLogxK
U2 - 10.1016/j.jcrc.2019.04.028
DO - 10.1016/j.jcrc.2019.04.028
M3 - Article
C2 - 31078997
AN - SCOPUS:85065389637
SN - 0883-9441
VL - 52
SP - 166
EP - 171
JO - Seminars in Anesthesia
JF - Seminars in Anesthesia
ER -